Liraglutide · GLP-1
Daily injection for appetite control
A once-daily GLP-1 injection that helps regulate hunger signals — prescribed off-label for weight management when clinically appropriate, with ongoing physician oversight.
HIPAA CompliantLicensed PhysiciansFDA-Approved RxTelehealth Care
The Ongo difference
Physician-guided care, built around you
Weight loss support
GLP-1 therapy that works with your natural appetite signals for gradual, sustainable progress.
Medical guidance
Every patient is evaluated by a licensed clinician before any prescription is considered.
Personalized plans
Dosing schedules tailored to your tolerance, goals, and clinician recommendations.
Ongoing coaching
Care Team support from evaluation through delivery and beyond.
About Liraglutide
What is Liraglutide?
Liraglutide is a GLP-1 receptor agonist available under brand names including Victoza® (for type 2 diabetes) and Saxenda® (FDA-approved for weight management). It mimics a natural hormone to slow digestion and reduce appetite.
See if you qualify →How it works
How does Liraglutide work?
Liraglutide activates GLP-1 receptors to slow gastric emptying and signal fullness to the brain — helping reduce calorie intake under clinician supervision.
Get Started Now →Your journey
Our step-by-step process
Complete your free online evaluation
Share your health history, goals, and BMI through our secure intake — takes about 5 minutes.
Meet with a licensed clinician
A board-certified provider reviews your case via telehealth and determines if liraglutide is appropriate.
Receive your personalized plan
If prescribed, your clinician creates a titration schedule tailored to your tolerance and progress.
Medication delivered to your door
Your prescription ships discreetly from a licensed U.S. pharmacy with ongoing Care Team support.
Is liraglutide right for you?
- Adults with obesity (BMI ≥ 30)
- Adults overweight (BMI ≥ 27) with a weight-related condition
- Committed to nutrition and activity changes alongside medication
- No contraindications identified by your clinician
Safety
Important safety information
Common side effects
Nausea, vomiting, diarrhea, and constipation — especially when starting or increasing dose.
Serious risks
Thyroid tumor risk in rodents. Not for medullary thyroid carcinoma or MEN 2 history.
Do not use if
Pregnant, breastfeeding, or allergic to liraglutide.
Talk to your doctor
Brand and indication vary. Your Ongo clinician determines the appropriate option.
Clinical trial highlights
| Measure | Liraglutide | Placebo |
|---|---|---|
| Avg. weight change (56 weeks) | −8.0% | −2.6% |
| Patients losing ≥5% body weight | 63% | 27% |
| Patients losing ≥10% body weight | 33% | 10% |
*Based on SCALE trial data. Individual results vary.
Watch our liraglutide overview
How to inject liraglutide
- Wash hands and attach a new needle to the pen.
- Select your dose per clinician instructions.
- Inject into abdomen, thigh, or upper arm.
- Dispose of the needle safely after each use.
Rotate injection sites daily. Store pen refrigerated before first use.
AbdomenFront of thighUpper arm
Dosage & administration
Liraglutide is started at a low dose and increased weekly. Your clinician personalizes the schedule.
- Week 1: 0.6 mg once daily
- Week 2: 1.2 mg once daily
- Week 3: 1.8 mg once daily
- Week 4: 2.4 mg once daily
- Week 5+: 3.0 mg once daily (maintenance)
Social proof
Patient testimonials
Real stories from patients on physician-guided liraglutide care.
The appetite changes were noticeable within the first few weeks. Having a real doctor guide the dosing made me feel safe the whole way.
Sarah M.
Ongo patient · on liraglutide
I appreciated that nobody rushed me. The evaluation was thorough, and my care team answered every question before I started.
James T.
4,000+Patients trust Ongo
Meet our medical team
Dr. Miller
Licensed Physician
Physician-guided weight loss and metabolic health consultations.
Dr. Niles
Board-Certified Physician
30+ years of clinical experience in patient-centered obesity care.
Dr. Krasne
Licensed Physician
Board-certified clinician focused on individualized treatment planning.
Dr. Bugailiskis
Board-Certified Physician
Evaluates patients based on health history, goals, and clinical needs.
Saxenda® (liraglutide 3.0 mg) is FDA-approved for weight management. Victoza® is approved for type 2 diabetes. Your clinician determines the right option.
Liraglutide is injected daily; Wegovy (semaglutide) is weekly. Both are GLP-1 agonists with different molecules and dosing.
Yes — if clinically appropriate after evaluation.
Ready to see if liraglutide is right for you?
Take a free evaluation. A licensed clinician will review your history and recommend a plan.
Get Started →Victoza® and Saxenda® are registered trademarks of Novo Nordisk. Educational content only — not medical advice.